We came across a bullish thesis on Ocular Therapeutix, Inc. on TipRanks’ YouTube channel. In this article, we will summarize ...

AbbVie's major drugs, Skyrizi and Rinvoq, are generating lots of sales. Realty Income's diversified portfolio provides plenty of protection and monthly income. The JEPQ ETF employs a covered-call ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Cosmetic injections are one of our biggest beauty obsessions, but what could be in that syringe? Health officials across America are warning of a rise in unlicensed operators injecting cheap, ...

Please provide your email address to receive an email when new articles are posted on . Three women experienced severe illness after self-injecting botulinum neurotoxin they purchased online from Asia ...

Temporarily shutting down a "lazy eye" triggers a burst of neuronal activity that reverses the condition in animal experiments, a study shows. When you purchase through links on our site, we may earn ...

The CDC reported that three individuals were hospitalized with botulism-type symptoms in May and June following self-injection of botulinum toxin they purchased online for cosmetic use. The case ...

Ulcerative colitis is a chronic, immune-mediated inflammatory bowel disease affecting the large intestine, causing persistent inflammation and ulceration of the colon’s lining. Common symptoms include ...

SKYRIZI ® (risankizumab), an IL-23 inhibitor, received two consecutive positive reimbursement recommendations by Canada’s Drug Agency (CDA-AMC) for inflammatory bowel diseases, initially for Crohn’s ...

Tenable security researchers have discovered seven new ways to extract private data from chat histories, largely through indirect prompt injections that exploit default ChatGPT features. AI chatbots ...

Sherri Gordon, CLC is a certified professional life coach, author, and journalist covering health and wellness, social issues, parenting, and mental health. She also has a certificate of completion ...